Robert (Bob) H. Underwood, PhD, helps clients achieve business objectives by drawing on his extensive experience establishing US and international intellectual property (IP) rights and identifying and evaluating third-party IP risks. He focuses his practice on the life sciences and chemical industries, including biologic and small-molecule pharmaceuticals and diagnostics, vaccines, medical devices, food science and nutritional supplements, agricultural technology, renewable and clean chemical technology, organic chemistry, polymers and catalysts.

Show More


  • Serves as IP counsel to Novartis on several transactions, including the approximately $7 billion sale of its vaccines business to GlaxoSmithKline, the sale of its influenza vaccines business to CSL and in evaluating business development opportunities
  • Serves as counsel to pharmaceutical companies for early stage evaluation of potential in-licensing and M&A opportunities
  • Served as IP transaction counsel, pro bono, to the ALS association

Show More


  • Chambers USA 2012 to present
  • Intellectual Asset Management (IAM) Patent 1000 – The World’s Leading Patent Practitioners 2012 to present
  • The Legal 500 US 2014 to present
  • World Intellectual Property Review patent leader 2016 to present


Suffolk University Law School, JD, cum laude, 2005
Tufts University, PhD, Immunology, 1998
University of New Hampshire, BS, Biology, 1989


Courts / Agencies
US Patent and Trademark Office

Robert H. Underwood, PhD

Insights & Events / Media

Burlington, Massachusetts / McDermott Event / February 13, 2018

Cambridge, Massachusetts / McDermott Event / October 4, 2017

Webinar / Speaking Engagements / September 28, 2017

Burlington, Massachusetts / McDermott Event / January 17, 2017